Their screening identified mitochondrial pathway components as crucial for the survival of these cells, proposing mitochondrial inhibition as a therapeutic strategy for KRAS mutant colon cancer.482 Hu et al. utilized CRISPR/Cas9 gene knockout to identify nine genes associated with colon cancer, which could serve as potential therapeutic targets. Here, KRAS is linked to colonic neoplasm.